{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:38:54Z","timestamp":1783021134373,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1SC2AI090922-01"],"award-info":[{"award-number":["1SC2AI090922-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 RR026139"],"award-info":[{"award-number":["U54 RR026139"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["8U54M D007587"],"award-info":[{"award-number":["8U54M D007587"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","award":["1R01CA282424-01"],"award-info":[{"award-number":["1R01CA282424-01"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijid.2025.108195","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:13:56Z","timestamp":1762902836000},"page":"108195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Seroprevalence of nine human papillomavirus types included in the nonavalent vaccine in unvaccinated women living in Puerto Rico: A population-based study"],"prefix":"10.1016","volume":"163","author":[{"given":"A.","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Ramos-Cartagena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Romaguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.R.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1017-9473","authenticated-orcid":false,"given":"A.P.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijid.2025.108195_bib0001","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.ijid.2025.108195_bib0002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/jiv403","article-title":"Seroprevalence of 9 human papillomavirus types in the United States, 2005-2006","volume":"213","author":"Liu","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108195_bib0003","year":"2024","journal-title":"Incidence and mortality file of the Puerto Rico Central Cancer Registry, 2017-2021"},{"key":"10.1016\/j.ijid.2025.108195_sbref0004","series-title":"U.S. Cancer Statistics Data Visualizations Tool, based on 2022 submission data (1999-2020): U.S","year":"2024"},{"key":"10.1016\/j.ijid.2025.108195_sbref0005","series-title":"Cervical Cancer Elimination Initiative","year":"2024"},{"issue":"26","key":"10.1016\/j.ijid.2025.108195_bib0006","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"Human Papillomavirus-Associated Cancers \u2014 United States, 2008-2012","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.ijid.2025.108195_bib0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108195_bib0008","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.5888\/pcd18.210035","article-title":"HPV vaccine school entry requirement in Puerto Rico: historical context, challenges, and opportunities","volume":"18","author":"Col\u00f3n-L\u00f3pez","year":"2021","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.ijid.2025.108195_bib0009","article-title":"Centers for Disease Control and Prevention","year":"2023","journal-title":"Immunize.org HPV Vaccine Requirements for Secondary School"},{"key":"10.1016\/j.ijid.2025.108195_bib0010","series-title":"Medical Clinics of North America","first-page":"1063","author":"Eun","year":"2020"},{"issue":"11","key":"10.1016\/j.ijid.2025.108195_bib0011","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1158\/1055-9965.EPI-20-0596","article-title":"Changes in HPV Seroprevalence from an Unvaccinated toward a Girls-Only Vaccinated Population in the Netherlands","volume":"29","author":"Pasmans","year":"2020","journal-title":"Cancer Epidemiology Biomarkers and Prevention"},{"key":"10.1016\/j.ijid.2025.108195_bib0012","first-page":"1011","article-title":"Seroprevalence of human papillomavirus 6\/11\/16\/18 among self-identified gay\/bisexual men who have sex with men, men who have sex with women, and females, United States, 2003-2010","volume":"69","author":"Lewis","year":"2019"},{"key":"10.1016\/j.ijid.2025.108195_sbref0013","series-title":"National Health and Nutrition Examination Survey Data","year":"2024"},{"key":"10.1016\/j.ijid.2025.108195_bib0014","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pvr.2018.03.006","article-title":"Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico","volume":"5","author":"Ortiz","year":"2018","journal-title":"Papillomavirus Res"},{"issue":"3","key":"10.1016\/j.ijid.2025.108195_bib0015","first-page":"117","article-title":"Methods in HPV surveillance: experiences from a Population-Based Study of HPV Infection among Women in the San Juan Metropolitan Area of Puerto Rico","volume":"34","author":"Ortiz","year":"2015","journal-title":"PR Health Sci J"},{"key":"10.1016\/j.ijid.2025.108195_bib0016","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pvr.2016.04.002","article-title":"Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico","volume":"2","author":"Ortiz","year":"2016","journal-title":"Papillomavirus Research"},{"key":"10.1016\/j.ijid.2025.108195_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113136","article-title":"Multiplex immunoassay to measure antibody response to nine HPV vaccine types","volume":"498","author":"Panicker","year":"2021","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.ijid.2025.108195_bib0018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/LGT.0000000000000504","article-title":"Association of body mass index with adherence to cervical cancer screening recommendations in hispanic women","volume":"24","author":"P\u00e9rez","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"13","key":"10.1016\/j.ijid.2025.108195_bib0019","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2020.02.017","article-title":"High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands","volume":"38","author":"Vos","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2025.108195_sbref0020","series-title":"R: A language and environment for statistical computing","year":"2021"},{"issue":"1","key":"10.1016\/j.ijid.2025.108195_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262724","article-title":"Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil","volume":"17","author":"Miyaji","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.108195_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijid.2019.03.022","article-title":"Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany \u2014 Results from a nationwide population-based survey","volume":"83","author":"Loenenbach","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2025.108195_bib0023","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.vaccine.2023.01.008","article-title":"The second HPV serology meeting: Progress and challenges in standardization of human papillomavirus serology assays","volume":"41","author":"Park","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2025.108195_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200236","article-title":"Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women","volume":"13","author":"Brown","year":"2022","journal-title":"Tumour Virus Res"},{"issue":"7","key":"10.1016\/j.ijid.2025.108195_bib0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1086\/604729","article-title":"Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National health and nutrition examination survey 2003-2004","volume":"200","author":"Markowitz","year":"2009","journal-title":"J Infec Dis"},{"issue":"6","key":"10.1016\/j.ijid.2025.108195_bib0026","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/sextrans-2013-051490","article-title":"Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003-2006","volume":"90","author":"Introcaso","year":"2014","journal-title":"Sex Transm Infect"},{"issue":"47","key":"10.1016\/j.ijid.2025.108195_bib0027","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1016\/j.vaccine.2012.08.068","article-title":"Seroprevalence of seven high-risk HPV types in The Netherlands","volume":"30","author":"Scherpenisse","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ijid.2025.108195_bib0028","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/infdis\/jix333","article-title":"Modeling of US human papillomavirus (HPV) seroprevalence by age and sexual behavior indicates an increasing trend of HPV infection following the sexual revolution","volume":"216","author":"Ryser","year":"2017","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2025.108195_bib0029","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/jog.13248","article-title":"Possible non-sexual modes of transmission of human papilloma virus. Vol. 43","volume":"43","author":"Sabeena","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"issue":"9","key":"10.1016\/j.ijid.2025.108195_bib0030","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1111\/j.1743-6109.2011.02329.x","article-title":"Sexual behaviors among adults in Puerto Rico: a population-based study","volume":"8","author":"Ortiz","year":"2011","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.ijid.2025.108195_bib0031","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-14-361","article-title":"Serological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile","volume":"14","author":"Castro","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2025.108195_bib0032","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/IGC.0b013e31823c2469","article-title":"Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia","volume":"22","author":"Bedoya","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ijid.2025.108195_bib0033","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV Types in cancers: Implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijid.2025.108195_bib0034","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.rmed.2017.03.030","article-title":"Recurrent respiratory papillomatosis: A state-of-the-art review","volume":"126","author":"Fortes","year":"2017","journal-title":"Respir Med"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2025.108195_bib0035","article-title":"Latin American and the Caribbean code against cancer 1st edition: infections and cancer","volume":"86","author":"Herrero","year":"2023","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ijid.2025.108195_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106400","article-title":"Cervical cancer screening in the United States: challenges and potential solutions for underscreened groups","author":"Fuzzell","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.ijid.2025.108195_sbref0037","series-title":"PR HPV Success Story","year":"2020"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:46:24Z","timestamp":1783017984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225004175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"alternative-id":["S1201971225004175"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108195","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of nine human papillomavirus types included in the nonavalent vaccine in unvaccinated women living in Puerto Rico: A population-based study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108195"}}